Longitudinal Changes In Epigenetic Measures Over 2 Years: Methodological Implications

Clock
Analytical
Epigenetic measures, especially those using principal component (PC) clocks, demonstrate stability and predictability over a two-year period in healthy older adults, indicating they may not be highly sensitive to short-term biological changes.
Author

Gemini

Published

November 25, 2025

Our bodies have a fascinating way of keeping track of time, not just by the years we live, but also at a cellular level. This “biological clock” is often studied using something called “epigenetic clocks,” which are based on changes to our DNA, specifically a process called DNA methylation. Think of DNA methylation as tiny chemical tags on our genes that can influence how they behave without changing the underlying genetic code itself. These tags accumulate or change over time, and scientists can use them to estimate a person’s biological age, which can sometimes differ from their chronological age.

Recently, researchers investigated how these epigenetic clocks behave over a relatively short period—two years—in a group of healthy older adults. The goal was to understand if these biological age measures fluctuate significantly in the short term, which is crucial for their use in studies, especially those testing interventions aimed at slowing down aging.

The study found that certain types of epigenetic clocks, particularly those that use a statistical technique called principal component analysis (referred to as PC clocks), were remarkably stable and predictable over the two-year period. This means that an individual’s biological age, as measured by these PC clocks, didn’t change drastically from one year to the next. While some small, statistically detectable increases in biological age were observed for certain PC clocks, these changes were numerically very small.

This stability suggests that these epigenetic measures might not be highly sensitive to very short-term biological shifts. For future research, especially clinical trials looking at aging, this is an important finding. It implies that these stable measures can be reliably used to track longer-term changes and that specific statistical methods, like ANCOVA, are well-suited for analyzing data from such trials. This work provides valuable information for designing more effective and powerful studies to understand and potentially influence the aging process.


Source: link to paper